According to Prime Medicine's latest financial reports the company has A$0.30 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | A$0.30 B | 71.45% |
2023-12-31 | A$0.17 B | -58.65% |
2022-12-31 | A$0.43 B | 16.14% |
2021-12-31 | A$0.37 B | 436.24% |
2020-12-31 | A$69.35 M |